Cargando…
Identification and validation of differentially expressed genes for targeted therapy in NSCLC using integrated bioinformatics analysis
BACKGROUND: Despite the high prevalence of lung cancer, with a five-year survival rate of only 23%, the underlying molecular mechanisms of non-small cell lung cancer (NSCLC) remain unknown. There is a great need to identify reliable candidate biomarker genes for early diagnosis and targeted therapeu...
Autores principales: | Altaf, Reem, Ilyas, Umair, Ma, Anmei, Shi, Meiqi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10264625/ https://www.ncbi.nlm.nih.gov/pubmed/37324026 http://dx.doi.org/10.3389/fonc.2023.1206768 |
Ejemplares similares
-
Recent advances in immune checkpoint inhibitors for non-small lung cancer treatment
por: Altaf, Reem, et al.
Publicado: (2022) -
Identification and Validation of Hub Genes Associated With Hepatocellular Carcinoma Via Integrated Bioinformatics Analysis
por: Wang, Sumei, et al.
Publicado: (2021) -
Identification and Validation of Hub Genes Associated with Bladder Cancer by Integrated Bioinformatics and Experimental Assays
por: Chen, Kang, et al.
Publicado: (2021) -
Identification of Core Genes and Screening of Potential Targets in Glioblastoma Multiforme by Integrated Bioinformatic Analysis
por: Yang, Ji’an, et al.
Publicado: (2021) -
Identification and Validation of SNP-Containing Genes With Prognostic Value in Gastric Cancer via Integrated Bioinformatics Analysis
por: Li, Hui, et al.
Publicado: (2021)